Jeff Yass’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-185,800
Closed -$3.71M 14627
2022
Q3
$3.71M Buy
+185,800
New +$2.45M ﹤0.01% 3672

Jeff Yass's FMTX Position: Q4 2022 in Review

Jeff Yass sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q4 2022, closing a stake of 13,647 shares — an estimated $272K sold.

Jeff Yass first reported a position in FMTX in Q4 2020 and held it in 8 quarters. The position peaked at $1.6M in Q1 2021. 0 funds tracked by Wall St. Rank hold FMTX as of Q4 2022.

  • Jeff Yass reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Jeff Yass sold 13,647 Forma Therapeutics Holdings, Inc. Common Stock shares in Q4 2022, an estimated $272K.
  • Jeff Yass first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q4 2020 and held it in 8 quarters.
  • Jeff Yass's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $1.6M in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q4 2022.

Based on Susquehanna International Group's 13F filing for Q4 2022, filed 14 Feb 2023.